Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:31 PM ET Form 4
Insider Selling Cardlytics, Inc. CDLX

Cardlytics CEO Amit Gupta Sells $46.7K of Stock

Amit Gupta, CEO, sold 17,733 shares of Cardlytics, Inc. at $2.53 to $2.71 a share (average $2.64) in 2 transactions, worth $46.7K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 138,906 (-5.0%).

Value
$46.7K
Shares
17,733
Average price
$2.64
Role
CEO
Holding change
-5.0%
Trade date
Oct 1, 2026 to Oct 2, 2026
5:21 PM ET Form 4
Insider Selling Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics CLO Christine Ring Sells $134K of Stock

Christine Ring, CLO, sold 5,786 shares of Nurix Therapeutics, Inc. at $23.19 a share, worth $134K in total on Oct 2, 2026. Shares held after the trade: 9,110 (-38.8%).

Value
$134K
Shares
5,786
Price
$23.19
Role
CLO
Holding change
-38.8%
Trade date
Oct 2, 2026
5:20 PM ET Form 4
Insider Selling PTC Therapeutics, Inc. PTCT

PTC Therapeutics Director Glenn Steele Jr. Md. Phd. Sells $782K of Stock

Glenn Steele Jr. Md. Phd., Director, sold 12,000 shares of PTC Therapeutics, Inc. at $65.16 a share, worth $782K in total on Sep 30, 2026. Shares held after the trade: 22,500 (-34.8%).

Value
$782K
Shares
12,000
Price
$65.16
Role
Director
Holding change
-34.8%
Trade date
Sep 30, 2026
5:20 PM ET Form 4
Insider Selling Rocket Lab Corp RKLB

Rocket Lab CFO Adam C. Spice Sells $9.93M of Stock

Adam C. Spice, CFO, sold 140,157 shares of Rocket Lab Corp at $70.28 to $71.79 a share (average $70.82) in 3 transactions, worth $9.93M in total on Oct 1, 2026. Shares held after the trade: 1,155,967 (-1.3%).

Value
$9.93M
Shares
140,157
Average price
$70.82
Role
CFO
Holding change
-1.3%
Trade date
Oct 1, 2026
5:20 PM ET Form 4
Insider Selling Ceribell, Inc. CBLL

Ceribell CTO Raymond Woo Sells $119K of Stock

Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $24.38 a share, worth $119K in total on Oct 1, 2026. Shares held after the trade: 203,118 (-2.3%).

Value
$119K
Shares
4,887
Price
$24.38
Role
CTO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals CFO Avraham Gabay Sells $90.2K of Stock

Avraham Gabay, CFO, sold 20,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $90.2K in total on Oct 1, 2026. Shares held after the trade: 861,076 (-2.3%).

Value
$90.2K
Shares
20,000
Price
$4.51
Role
CFO
Holding change
-2.3%
Trade date
Oct 1, 2026
5:19 PM ET Form 4
Insider Selling Oramed Pharmaceuticals Inc. ORMP

Oramed Pharmaceuticals COO & Cbo Joshua Hexter Sells $135K of Stock

Joshua Hexter, COO & Cbo, sold 30,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $135K in total on Oct 1, 2026. Shares held after the trade: 1,328,130 (-2.2%).

Value
$135K
Shares
30,000
Price
$4.51
Role
COO & Cbo
Holding change
-2.2%
Trade date
Oct 1, 2026
5:16 PM ET Form 4
Insider Selling Verastem, Inc. VSTM

Verastem President and CEO Dan Paterson Sells $353K of Stock

Dan Paterson, President and CEO, sold 44,121 shares of Verastem, Inc. at $8.00 a share, worth $353K in total on Oct 1, 2026. Shares held after the trade: 652,712 (-6.3%).

Value
$353K
Shares
44,121
Price
$8.00
Role
President and CEO
Holding change
-6.3%
Trade date
Oct 1, 2026
5:15 PM ET Form 4
Insider Selling Verastem, Inc. VSTM

Verastem CFO Daniel Calkins Sells $20.5K of Stock

Daniel Calkins, CFO, sold 2,566 shares of Verastem, Inc. at $8.00 a share, worth $20.5K in total on Oct 1, 2026. Shares held after the trade: 123,781 (-2.0%).

Value
$20.5K
Shares
2,566
Price
$8.00
Role
CFO
Holding change
-2.0%
Trade date
Oct 1, 2026
5:14 PM ET Form 4
Insider Selling Coursera, Inc. COUR

Coursera President & CEO Gregory M. Hart Sells $52.6K of Stock

Gregory M. Hart, President & CEO, sold 10,308 shares of Coursera, Inc. at $5.11 a share, worth $52.6K in total on Oct 1, 2026. Shares held after the trade: 1,539,003 (-0.7%).

Value
$52.6K
Shares
10,308
Price
$5.11
Role
President & CEO
Holding change
-0.7%
Trade date
Oct 1, 2026
5:13 PM ET Form 4
Insider Selling Generac Holdings Inc. GNRC

Generac Holdings CEO Aaron Jagdfeld Sells $1.03M of Stock

Aaron Jagdfeld, CEO, sold 5,000 shares of Generac Holdings Inc. at $206.00 a share, worth $1.03M in total on Oct 1, 2026. Shares held after the trade: 544,528 (-0.9%).

Value
$1.03M
Shares
5,000
Price
$206.00
Role
CEO
Holding change
-0.9%
Trade date
Oct 1, 2026
5:10 PM ET Form 4
Insider Selling Warby Parker Inc. WRBY

Warby Parker Insider Jeffrey Jacob Raider Sells $416K of Stock

Jeffrey Jacob Raider sold 15,000 shares of Warby Parker Inc. at $27.70 a share, worth $416K in total on Oct 1, 2026. Shares held after the trade: 420,201 (-3.4%).

Value
$416K
Shares
15,000
Price
$27.70
Holding change
-3.4%
Trade date
Oct 1, 2026
5:09 PM ET Form 4
Insider Selling Warby Parker Inc. WRBY

Warby Parker Co-CEO Neil Harris Blumenthal Sells $2.77M of Stock

Neil Harris Blumenthal, Co-CEO, sold 100,000 shares of Warby Parker Inc. at $27.69 a share, worth $2.77M in total on Oct 1, 2026. Shares held after the trade: 36,020 (-73.5%).

Value
$2.77M
Shares
100,000
Price
$27.69
Role
Co-CEO
Holding change
-73.5%
Trade date
Oct 1, 2026
5:01 PM ET Form 4
Insider Selling Tectonic Therapeutic, Inc. TECX

Tectonic Therapeutic CSO Peter McNamara Sells $12.3K of Stock

Peter McNamara, CSO, sold 536 shares of Tectonic Therapeutic, Inc. at $23.04 a share, worth $12.3K in total on Sep 30, 2026. Shares held after the trade: 54,305 (-1.0%).

Value
$12.3K
Shares
536
Price
$23.04
Role
CSO
Holding change
-1.0%
Trade date
Sep 30, 2026
5:00 PM ET Form 4
Insider Selling Bloom Energy Corp BE

Bloom Energy Chief Commercial Officer Aman Joshi Sells $2.34M of Stock

Aman Joshi, Chief Commercial Officer, sold 8,437 shares of Bloom Energy Corp at $277.17 a share, worth $2.34M in total on Oct 1, 2026. Shares held after the trade: 147,092 (-5.4%).

Value
$2.34M
Shares
8,437
Price
$277.17
Role
Chief Commercial Officer
Holding change
-5.4%
Trade date
Oct 1, 2026
4:58 PM ET Form 4
Insider Selling Credo Technology Group Holding Ltd CRDO

Credo Technology Group Holding COO Yat Tung Lam Sells $10.3M of Stock

Yat Tung Lam, COO, sold 50,000 shares of Credo Technology Group Holding Ltd at $205.22 a share, worth $10.3M in total on Oct 1, 2026. Shares held after the trade: 2,254,169 (-2.2%).

Value
$10.3M
Shares
50,000
Price
$205.22
Role
COO
Holding change
-2.2%
Trade date
Oct 1, 2026
4:56 PM ET Form 4
Insider Selling Maximus, Inc. MMS

Maximus Chief of Human Resources Michelle F. Link Sells $174K of Stock

Michelle F. Link, Chief of Human Resources, sold 3,208 shares of Maximus, Inc. at $54.23 a share, worth $174K in total on Oct 1, 2026. Shares held after the trade: 13,881 (-18.8%).

Value
$174K
Shares
3,208
Price
$54.23
Role
Chief of Human Resources
Holding change
-18.8%
Trade date
Oct 1, 2026
4:55 PM ET Form 4
Insider Selling Verisign Inc VRSN

Verisign EVP, Gen Counsel & Secretary Thomas C. Indelicarto Sells $142K of Stock

Thomas C. Indelicarto, EVP, Gen Counsel & Secretary, sold 500 shares of Verisign Inc at $284.38 a share, worth $142K in total on Oct 1, 2026. Shares held after the trade: 32,395 (-1.5%).

Value
$142K
Shares
500
Price
$284.38
Role
EVP, Gen Counsel & Secretary
Holding change
-1.5%
Trade date
Oct 1, 2026
4:55 PM ET Form 4
Insider Selling Xeris Biopharma Holdings, Inc. XERS

Xeris Biopharma Holdings Insider Steven Pieper Sells $47K of Stock

Steven Pieper sold 5,000 shares of Xeris Biopharma Holdings, Inc. at $9.41 a share, worth $47K in total on Oct 1, 2026. Shares held after the trade: 1,351,053 (-0.4%).

Value
$47K
Shares
5,000
Price
$9.41
Holding change
-0.4%
Trade date
Oct 1, 2026
4:55 PM ET Form 4
Insider Selling Xeris Biopharma Holdings, Inc. XERS

Xeris Biopharma Holdings Insider Kevin McCulloch Sells $141K of Stock

Kevin McCulloch sold 15,000 shares of Xeris Biopharma Holdings, Inc. at $9.41 a share, worth $141K in total on Oct 1, 2026. Shares held after the trade: 1,599,208 (-0.9%).

Value
$141K
Shares
15,000
Price
$9.41
Holding change
-0.9%
Trade date
Oct 1, 2026
4:54 PM ET Form 4
Insider Selling Xeris Biopharma Holdings, Inc. XERS

Xeris Biopharma Holdings Insider Beth Hecht Sells $157K of Stock

Beth Hecht sold 16,666 shares of Xeris Biopharma Holdings, Inc. at $9.41 a share, worth $157K in total on Oct 1, 2026. Shares held after the trade: 1,111,130 (-1.5%).

Value
$157K
Shares
16,666
Price
$9.41
Holding change
-1.5%
Trade date
Oct 1, 2026
4:53 PM ET Form 4
Insider Selling BeOne Medicines Ltd. ONC

BeOne Medicines SVP, General Counsel Chan Henry Lee Sells $418K of Stock

Chan Henry Lee, SVP, General Counsel, sold 1,115 shares of BeOne Medicines Ltd. at $375.00 a share, worth $418K in total on Sep 30, 2026. Shares held after the trade: 0 (-100.0%).

Value
$418K
Shares
1,115
Price
$375.00
Role
SVP, General Counsel
Holding change
-100.0%
Trade date
Sep 30, 2026
4:49 PM ET Form 4
Insider Selling BJ's Wholesale Club Holdings, Inc. BJ

BJ's Wholesale Club Holdings EVP, Chief Growth Officer Timothy Pierce Morningstar Sells $457K of Stock

Timothy Pierce Morningstar, EVP, Chief Growth Officer, sold 4,856 shares of BJ's Wholesale Club Holdings, Inc. at $94.09 a share, worth $457K in total on Oct 1, 2026. Shares held after the trade: 33,924 (-12.5%).

Value
$457K
Shares
4,856
Price
$94.09
Role
EVP, Chief Growth Officer
Holding change
-12.5%
Trade date
Oct 1, 2026
4:49 PM ET Form 4
Insider Selling H&R Block Inc HRB

H&R Block Chief Retail Officer Mark J. Darling Sells $110K of Stock

Mark J. Darling, Chief Retail Officer, sold 2,700 shares of H&R Block Inc at $40.69 a share, worth $110K in total on Sep 30, 2026. Shares held after the trade: 21,588 (-11.1%).

Value
$110K
Shares
2,700
Price
$40.69
Role
Chief Retail Officer
Holding change
-11.1%
Trade date
Sep 30, 2026
4:49 PM ET Form 4
Insider Selling BJ's Wholesale Club Holdings, Inc. BJ

BJ's Wholesale Club Holdings EVP, Strategy & Development William C. Werner Sells $285K of Stock

William C. Werner, EVP, Strategy & Development, sold 3,000 shares of BJ's Wholesale Club Holdings, Inc. at $95.00 a share, worth $285K in total on Oct 1, 2026. Shares held after the trade: 50,160 (-5.6%).

Value
$285K
Shares
3,000
Price
$95.00
Role
EVP, Strategy & Development
Holding change
-5.6%
Trade date
Oct 1, 2026
4:44 PM ET Form 4
Insider Selling Nwpx Infrastructure, Inc. NWPX

Nwpx Infrastructure SVP and Group President of WTS Eric Stokes Sells $1.28M of Stock

Eric Stokes, SVP and Group President of WTS, sold 12,353 shares of Nwpx Infrastructure, Inc. at $103.38 a share, worth $1.28M in total on Oct 1, 2026. Shares held after the trade: 25,274 (-32.8%).

Value
$1.28M
Shares
12,353
Price
$103.38
Role
SVP and Group President of WTS
Holding change
-32.8%
Trade date
Oct 1, 2026
4:42 PM ET Form 4
Insider Selling On Semiconductor Corp ON

On Semiconductor Group President, AMG & ISG Sudhir Gopalswamy Sells $1.25M of Stock

Sudhir Gopalswamy, Group President, AMG & ISG, sold 15,578 shares of On Semiconductor Corp at $80.00 a share, worth $1.25M in total on Oct 1, 2026. Shares held after the trade: 158,177 (-9.0%).

Value
$1.25M
Shares
15,578
Price
$80.00
Role
Group President, AMG & ISG
Holding change
-9.0%
Trade date
Oct 1, 2026
4:41 PM ET Form 4
Insider Selling Powell Industries Inc POWL

Powell Industries VP, R&D William Marshall Mauney Jr. Sells $56.5K of Stock

William Marshall Mauney Jr., VP, R&D, sold 301 shares of Powell Industries Inc at $187.67 a share, worth $56.5K in total on Sep 30, 2026. Shares held after the trade: 10,552 (-2.8%).

Value
$56.5K
Shares
301
Price
$187.67
Role
VP, R&D
Holding change
-2.8%
Trade date
Sep 30, 2026
4:40 PM ET Form 4
Insider Selling Gilead Sciences, Inc. GILD

Gilead Sciences Chairman & CEO Daniel Patrick O'Day Sells $2.22M of Stock

Daniel Patrick O'Day, Chairman & CEO, sold 15,000 shares of Gilead Sciences, Inc. at $147.72 to $148.63 a share (average $147.90) in 2 transactions, worth $2.22M in total on Oct 1, 2026. Shares held after the trade: 566,683 (-0.5%).

Value
$2.22M
Shares
15,000
Average price
$147.90
Role
Chairman & CEO
Holding change
-0.5%
Trade date
Oct 1, 2026
4:38 PM ET Form 4
Insider Selling Halozyme Therapeutics, Inc. HALO

Halozyme Therapeutics Insider Matthew L. Posard Sells $568K of Stock

Matthew L. Posard sold 5,230 shares of Halozyme Therapeutics, Inc. at $107.17 to $110.04 a share (average $108.54) in 4 transactions, worth $568K in total on Oct 1, 2026. Shares held after the trade: 53,609 (-0.2%).

Value
$568K
Shares
5,230
Average price
$108.54
Holding change
-0.2%
Trade date
Oct 1, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.